Skip to content
Apices CRO
Global Clinical Research Support
Apices CROApices CRO
ContactSubmit RFP
  • Customer Corner
  • EDC
  • APICES Platforms
  • GLASS
.
  • Menu iconAbout us
  • Menu iconServices
    • Project Design
    • Project Management
    • Start-Up
    • Monitoring
    • Data Management
    • Pharmacovigilance
    • Biostatistics
    • Quality Assurance
    • Medical Writing
    • Medical Monitoring
    • Other services
  • Experience
    • Clinical Trials
    • Non-interventional Studies
    • Real-World Evidence Studies
  • Menu iconPolicies
  • Menu iconWork with us
  • Menu iconNews
  • Menu iconWhite Papers
  • Menu iconAbout us
  • Menu iconServices
    • Project Design
    • Project Management
    • Start-Up
    • Monitoring
    • Data Management
    • Pharmacovigilance
    • Biostatistics
    • Quality Assurance
    • Medical Writing
    • Medical Monitoring
    • Other services
  • Experience
    • Clinical Trials
    • Non-interventional Studies
    • Real-World Evidence Studies
  • Menu iconPolicies
  • Menu iconWork with us
  • Menu iconNews
  • Menu iconWhite Papers

News

You are here:
  1. Home
  2. Entries tagged with "APICES"
May122021

GESTO platform: Publication of results of observational studies with medicinal products for human use

GESTO platform: Publication of results of observational studies with medicinal products for human use After approval of the RD 957/2020 which regulates observational studies with medicinal products for human use it is mandatory the publication of results of…

Read more

Acknowledgment for APICES collaboration in BIBABRAX Study published in Cancer Chemotherapy and Pharmacology

Acknowledgment for APICES collaboration in BIBABRAX Study published in Cancer Chemotherapy and Pharmacology Once again, we are privileged to share the acknowledgment that APICES has received in the recent publication titled “Phase II clinical trial of nab‑paclitaxel plus…

Read more
Dec42020

New regulation for observational studies with medicines for human use in Spain

New regulation for observational studies with medicines for human use in Spain Last week, the Royal Decree 957/2020 which regulates the observational studies with medicines for human use was published in the BOE. This regulation will come into…

Read more
Oct12020

Acknowledgment for APICES collaboration in a study published in Blood Cells, Molecules, and Diseases.

Acknowledgment for APICES collaboration in a study published in Blood Cells, Molecules, and Diseases. This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A decade of changes in management of…

Read more
Jun12020

Acknowledgment for APICES collaboration in DUTRENEO study presented as ORAL PRESENTATION at ASCO 2020 Annual Meeting.

Acknowledgment for APICES collaboration in DUTRENEO study presented as ORAL PRESENTATION at ASCO 2020 Annual Meeting. We want to share the acknowledgment that APICES has received in a recent ORAL PRESENTATION at the ASCO 2020 Annual Meeting by Dr. Enrique Grande. APICES…

Read more
Jan292020

Acknowledgment for APICES collaboration in STREAM study published in Clinical and Translational Oncology.

Acknowledgment for APICES collaboration in STREAM study published in Clinical and Translational Oncology. This month, we want to share the acknowledgment that APICES has received in a recent publication in Clinical and Translational Oncology in which APICES has…

Read more
Nov142019

Acknowledgment for APICES collaboration in a clinical trial published in Scientific Reports.

Acknowledgment for APICES collaboration in a clinical trial published in Scientific Reports. This month, we want to share the acknowledgment that APICES has received in a recent publication in Scientific Reports in which APICES has collaborated in several…

Read more
Sep252019

Acknowledgment for APICES collaboration in a clinical trial published in BMC Cancer.

Acknowledgment for APICES collaboration in a clinical trial published in BMC Cancer. This month, we want to share the acknowledgment that APICES has received in a recent publication in BMC Cancer in which APICES has collaborated in several…

Read more
Jun42019

ICH Releases Draft Revision of E8 Guideline, General Considerations for Clinical Trials

ICH Releases Draft Revision of E8 Guideline, General Considerations for Clinical Trials Since the last update of ICH6 (R2) on 2017, ICH was working on a new release, a new revision of ICH E8 about General Considerations for…

Read more
May152019

Acknowledgment for APICES collaboration in a clinical trial published in The Oncologist.

Acknowledgment for APICES collaboration in a clinical trial published in The Oncologist. Many times the work of CROs is not totally acknowledged. But, fortunately, this is not always the case. This month, we want to share the acknowledgment…

Read more
←1
2
…34567→
null
info@apices.es
null
www.apices.es
Twitterlinkedin
null

PARÍS

+33 (0)1 44 82 74 74
4 Rue de Cléry, 75002 Paris, France
null

MADRID HEADQUARTERS

+34 91 816 68 04
Av. Antonio López, 16
1st floor 28320 Pinto (Madrid), Spain
null
ACKNOWLEDGEMENTS
null
CERTIFICATIONS
certification ISO 9001 SGQ  certification IQNET  certification ISO 26001  certification GRI
certification CIR France certification CSR certification CSR certification CSR
null
COURSES
Course for healthcare professionals on Good Clinical Practice (GCP)
  • Terms of service
  • Privacy policy
  • Cookie Policy
Avisos Legales
Go to Top
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
  • English